Literature DB >> 9586415

[Low levels of HDL cholesterol in hypothyroid patients with cardiovascular diseases].

M Carantoni1, G B Vigna, N Stucci, R Zanca, R Fellin.   

Abstract

BACKGROUND: Hypothyroidism is a frequent cause of hyperlipidemia, particularly in women, but its true prevalence, both in the general population and in dyslipidemic subjects, is unknown. It is uncertain if low thyroid function significantly influence HDL metabolism and if sub-clinical disease may cause metabolic abnormalities and increase cardiovascular risk.
METHODS: Three-hundred and three consecutive female patients (mean age 59.2 +/- 0.5 yrs), observed in a metabolic ward because of dyslipidemia, were evaluated.
RESULTS: Forty-three women (14.1% of the total) showed sub-clinical hypothyroidism, while in 12 cases (4.0%) overt hypothyroidism was diagnosed; 8 further women (2.6%) had been previously diagnosed to be hypothyroid and were under hormone replacement therapy. On the whole, hypothyroid patients showed higher mean triglyceride levels and lower HDL-cholesterol than dyslipidemic euthyroid women, but the difference did not reach statistical significance. Total cholesterol concentration did not change with impaired thyroid function. Hypothyroid patients reported a clinical history of cardiovascular disease, or had severe atherosclerosis demonstrated, more often than euthyroid subjects (25.0% vs 19.7%, p = n.s.). When only women with arterial disease were considered, HDL plasma levels were significantly lower in the hypothyroid than in the euthyroid group (44.3 +/- 3.1 vs 56.2 +/- 1.7 mg/dl, respectively; p < 0.01). Hypertriglyceridemia and obesity often coexisted.
CONCLUSIONS: In conclusion, among dyslipidemic women, unrecognised hypothyroidism is highly prevalent (both sub-clinical and manifest). In hypothyroid subjects atherosclerosis seem to associate with particularly low HDL plasma levels. This might precede atherosclerosis development (reinforced by concomitant thyroid failure) and represent a marker of the polymetabolic syndrome.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9586415

Source DB:  PubMed          Journal:  Minerva Endocrinol        ISSN: 0391-1977            Impact factor:   2.184


  3 in total

1.  Inherent suppression of thyroid stimulating hormone in newly diagnosed dyslipidemic patients - indication for use of thyromimetics?

Authors:  Sridevi V Udupa; Vivian D'Souza; Vinit A Udupa; Poornima A Manjrekar
Journal:  J Clin Diagn Res       Date:  2014-09-20

2.  Thyroid Symptomatology across the Spectrum of Hypothyroidism and Impact of Levothyroxine Supplementation in Patients with Severe Primary Hypothyroidism.

Authors:  Deep Dutta; Aakash Garg; Deepak Khandelwal; Sanjay Kalra; Suresh Mittal; Sachin Chittawar
Journal:  Indian J Endocrinol Metab       Date:  2019 May-Jun

3.  Thyroid dysfunction and their relation to cardiovascular risk factors such as lipid profile, hsCRP, and waist hip ratio in Korea.

Authors:  Chan Hee Jung; Ki Chul Sung; Hun Sub Shin; Eun Jung Rhee; Won Young Lee; Bum Soo Kim; Jin Ho Kang; Hyang Kim; Sun Woo Kim; Man Ho Lee; Jung Ro Park; Seon Woo Kim
Journal:  Korean J Intern Med       Date:  2003-09       Impact factor: 2.884

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.